background
winter
influenza
season
republ
korea
influenza
predomin
viru
first
peak
period
influenza
activ
second
half
januari
hand
influenza
b
predomin
viru
second
peak
period
influenza
activ
second
half
march
object
studi
compar
clinic
epidemiolog
characterist
patient
laboratoryconfirm
influenza
influenza
b
northern
hemispher
winter
influenza
season
temper
countri
northern
asia
influenza
influenza
b
peak
influenza
appear
first
republ
korea
japan
follow
influenza
b
revers
sequenc
occur
china
mongolia
republ
korea
influenza
predomin
viru
first
peak
period
influenza
activ
second
half
januari
hand
influenza
b
predomin
viru
second
peak
period
influenza
activ
second
half
march
republ
korea
influenza
b
increas
markedli
late
season
even
though
influenza
predomin
viru
winter
influenza
season
northern
hemispher
moreov
incid
influenza
b
influenza
season
much
higher
influenza
season
republ
korea
also
report
newli
emerg
reassort
differ
lineag
influenza
b
may
associ
unusu
influenza
b
epidem
therefor
increas
proport
influenza
b
deserv
analysi
monitor
influenza
b
influenza
studi
describ
clinic
characterist
influenza
b
infect
compar
clinic
epidemiolog
characterist
patient
laboratoryconfirm
influenza
influenza
b
prospect
observ
cohort
compar
clinic
characterist
clinic
outcom
patient
influenza
influenza
b
manag
control
influenza
viral
infect
futur
necessari
investig
clinic
demograph
data
adult
patient
laboratoryconfirm
influenza
influenza
b
infect
visit
emerg
depart
seven
univers
hospit
republ
korea
influenza
season
compar
clinic
manifest
laboratori
paramet
influenza
vaccin
rate
hospit
rate
clinic
outcom
mortal
adult
patient
influenza
influenza
b
infect
studi
prospect
conduct
seven
univers
hospit
korea
surveil
conduct
use
clinic
influenzalik
ill
ili
criteria
obtain
written
inform
consent
nasalthroat
swab
taken
patient
ili
rapid
influenza
detect
test
sd
biolin
influenza
antigen
testh
standard
diagnost
inc
korea
perform
bedsid
multiplex
respiratori
viral
polymeras
chain
reaction
test
seeplexh
ace
detect
seegen
korea
perform
use
nasalthroat
swab
specimen
central
laboratori
influenza
patient
confirm
complic
clinic
symptom
limit
physic
activ
sever
hospit
whether
patient
sever
clinic
symptom
requir
hospit
determin
infecti
diseas
specialist
thu
decis
recommend
hospit
patient
influenza
made
infecti
diseas
specialist
particip
hospit
basi
clinic
laboratori
radiolog
find
initi
present
number
laboratoryconfirm
case
distribut
influenza
type
estim
serial
analyz
data
adult
patient
ili
case
laboratoryconfirm
influenza
case
laboratoryconfirm
influenza
b
enrol
compar
prospect
clinic
symptom
influenza
vaccin
histori
comorbid
condit
laboratori
paramet
clinic
outcom
ili
clinic
defin
sudden
onset
fever
presenc
least
one
follow
respiratori
symptom
cough
sore
throat
rhinorrheanas
obstruct
laboratoryconfirm
influenza
defin
influenza
confirm
multiplex
respiratori
viral
polymeras
chain
reaction
pcr
use
nasalthroat
swab
specimen
pneumonia
defin
influenza
pulmonari
infiltr
andor
hypoxia
primari
viral
pneumonia
defin
pneumonia
without
document
bacteri
pathogen
combin
bacteri
pneumonia
defin
pneumonia
isol
signific
pathogen
respiratori
specimen
cultur
posit
result
urinari
antigen
test
complic
defin
spread
influenza
viru
infect
beyond
upper
respiratori
tract
involv
organ
includ
lower
respiratori
tract
surveil
began
octob
result
report
weekli
electron
data
report
system
throughout
follow
year
data
demograph
characterist
clinic
symptom
relev
physic
find
prior
histori
influenza
vaccin
underli
medic
condit
treatment
regimen
laboratori
result
day
hospit
stay
complic
influenza
influenzarel
mortal
collect
elig
patient
rna
extract
viral
transport
medium
done
use
nuclisen
easymag
franc
cdna
synthesi
perform
use
accupowerh
cyclescript
rt
premix
bioneer
korea
effect
independ
variabl
clinic
outcom
pvalu
twotail
test
consid
statist
signific
total
patient
ili
visit
emerg
room
seven
univers
hospit
korea
octob
may
screen
patient
case
laboratoryconfirm
influenza
case
laboratoryconfirm
influenza
b
enrol
prospect
compar
clinic
featur
laboratori
paramet
complic
clinic
outcom
figur
week
oct
oct
two
femal
patient
diagnos
laboratoryconfirm
influenza
laboratoryconfirm
influenza
began
seen
week
dec
dec
peak
week
jan
jan
influenza
season
laboratoryconfirm
influenza
b
began
seen
week
jan
jan
peak
week
mar
mar
influenza
season
number
patient
laboratoryconfirm
influenza
b
higher
number
laboratoryconfirm
influenza
week
mar
may
figur
patient
influenza
viru
infect
number
femal
higher
number
male
proport
femal
male
patient
significantli
higher
influenza
b
p
mean
age
patient
influenza
influenza
b
year
respect
age
significantli
higher
patient
influenza
underli
medic
condit
patient
includ
descend
order
frequenc
hypertens
diabet
mellitu
chronic
lung
diseas
cerebrovascular
disord
cardiovascular
disord
malign
pregnanc
chronic
hepat
diseas
chronic
renal
diseas
neuromuscular
diseas
frequenc
cardiovascular
disord
diabet
hypertens
significantli
higher
patient
influenza
rate
influenza
vaccin
patient
influenza
b
season
respect
tabl
initi
bodi
temperatur
patient
influenza
influenza
b
respect
p
signific
differ
frequenc
chill
cough
crackl
diarrhea
dyspnea
myalgia
seizur
sore
throat
sputum
wheez
tabl
influenza
influenza
b
patient
influenza
influenza
b
patient
test
routin
laboratori
find
initi
present
mean
age
influenza
patient
test
routin
laboratori
find
higher
patient
test
vs
year
frequenc
cardiovascular
disord
cerebrovascular
disord
chronic
lung
diseas
chronic
renal
diseas
diabet
hypertens
statist
higher
patient
test
routin
laboratori
find
initi
present
patient
influenza
statist
higher
white
blood
cell
count
higher
platelet
count
elev
creactiv
protein
level
influenza
b
though
statist
higher
patient
influenza
mean
white
blood
cell
platelet
count
patient
influenza
b
within
normal
limit
hand
frequenc
leukopenia
thrombocytopenia
patient
influenza
b
statist
higher
patient
influenza
tabl
signific
differ
initi
level
hemoglobin
erythrocyt
sediment
rate
alanin
transaminas
aspart
transaminas
bilirubin
albumin
serum
creatinin
lactat
dehydrogenas
creatin
phosphokinas
prothrombin
time
tabl
clinic
outcom
hospit
patient
laboratoryconfirm
influenza
influenza
b
shown
tabl
rate
hospit
overal
patient
influenza
b
respect
rate
hospit
length
hospit
stay
statist
higher
patient
influenza
tabl
howev
statist
signific
differ
proport
patient
hospit
day
influenza
b
patient
group
hospit
patient
frequenc
diabet
hypertens
case
least
one
comorbid
condit
proport
elderli
significantli
higher
patient
influenza
antivir
agent
prescript
rate
patient
hospit
influenza
b
respect
antibiot
prescript
rate
patient
hospit
influenza
b
patient
respect
influenza
complic
viral
pneumonia
bacteri
pneumonia
acut
renal
failur
occur
hospit
patient
influenza
howev
influenza
complic
viral
pneumonia
occur
patient
hospit
influenza
b
tabl
among
case
number
hospit
patient
nonhospit
patient
univari
analysi
proport
case
influenza
viru
type
ci
p
cardiovascular
disord
ci
cerebrovascular
disord
ci
chronic
tabl
multivari
analysi
cardiovascular
disord
ci
p
chronic
lung
diseas
ci
p
hypertens
ci
p
diabet
mellitu
ci
p
neuromuscular
diseas
ci
p
independ
associ
hospit
patient
laboratoryconfirm
influenza
tabl
influenza
season
acut
respiratori
infect
character
fever
upper
respiratori
symptom
signific
public
health
problem
associ
annual
season
outbreak
morbid
mortal
influenzarel
complic
especi
elderli
patient
patient
chronic
medic
condit
influenza
classifi
subtyp
influenza
b
classifi
subtyp
influenza
viral
infect
associ
sever
diseas
higher
pneumonia
influenza
mortal
one
studi
netherland
estim
mortal
attribut
common
viral
infect
week
week
show
proport
death
attribut
influenza
b
infect
regard
age
vs
year
vs
year
vs
year
respect
larg
variat
year
studi
statist
signific
differ
mortal
patient
infect
influenza
b
evolutionari
rate
influenza
b
viru
lower
influenza
viru
clinic
pictur
influenza
b
usual
milder
influenza
influenza
virus
infect
human
bird
pig
sever
speci
exchang
gene
differ
influenza
viru
strain
may
induc
develop
new
reassort
virus
pandem
potenti
furthermor
influenza
virus
differ
mechan
evad
earli
host
recognit
influenza
b
virus
easili
thu
earli
virushost
cell
interact
may
differ
influenza
b
virus
previous
report
studi
analyz
activ
antivir
respons
human
dendrit
cell
influenza
b
virus
influenza
b
viru
activ
transcript
factor
interferon
ifn
regulatori
factor
faster
rate
influenza
viru
studi
show
influenza
b
viru
induc
ifn
respons
even
infect
disabl
ultraviolet
light
therefor
initi
viral
transcript
replic
viral
protein
synthesi
unnecessari
influenza
b
virusinduc
antivir
respons
influenza
viral
infect
activ
ifn
respons
viral
rna
synthesi
thu
propos
earli
influenza
virushost
cell
interact
differ
influenza
b
virus
differ
earli
host
recognit
influenza
b
virus
may
associ
differ
influenza
viru
pathogen
clinic
manifest
outcom
earli
host
recognit
influenza
b
may
contribut
faster
effect
restrict
faster
clearanc
influenza
b
viral
infect
studi
patient
influenza
exhibit
statist
higher
white
blood
cell
count
platelet
count
creactiv
protein
level
neutrophil
percent
blood
patient
influenza
b
howev
mean
white
blood
cell
platelet
count
patient
influenza
b
within
normal
limit
hand
frequenc
leukopenia
thrombocytopenia
patient
influenza
b
statist
higher
patient
influenza
requir
monitor
analysi
leukocyt
platelet
count
patient
influenza
b
futur
furthermor
also
observ
differ
proport
femal
male
elderli
popul
patient
infect
influenza
b
suggest
age
sex
ratio
popul
might
factor
determin
rel
proport
influenza
b
viral
infect
certain
popul
even
though
studi
report
influenza
b
infect
caus
sever
infect
complic
pneumonia
death
especi
due
bacteri
coinfect
influenza
b
viru
overal
consid
less
pathogen
produc
milder
symptom
influenza
viru
adult
howev
influenza
viru
type
versu
b
shown
signific
independ
risk
factor
hospit
patient
influenza
multivari
analysi
moreov
frequenc
underli
comorbid
condit
proport
elderli
lower
patient
influenza
b
compar
influenza
studi
therefor
younger
age
lower
frequenc
underli
comorbid
condit
may
associ
milder
clinic
cours
patient
influenza
b
viral
infect
possibl
exist
influenza
b
viru
less
pathogen
also
abl
confirm
underli
chronic
diseas
cardiovascular
disord
chronic
lung
diseas
hypertens
diabet
mellitu
neuromuscular
diseas
import
factor
determin
hospit
patient
laboratoryconfirm
influenza
howev
studi
limit
first
influenza
case
studi
select
sampl
select
patient
visit
emerg
room
result
patient
visit
emerg
room
exclud
could
repres
sampl
bia
second
sinc
sensit
rtpcr
true
influenza
posit
patient
might
regard
influenza
neg
third
routin
laboratori
test
white
blood
cell
blood
platelet
count
perform
estim
enrol
patient
fourth
data
regard
comorbid
condit
might
underestim
analyz
emerg
room
medic
record
fifth
data
whether
mismatch
differ
strain
viru
isol
influenza
vaccin
season
analyz
detail
sequenc
data
conclus
proport
male
femal
elderli
popul
significantli
higher
influenza
patient
group
compar
influenza
b
group
hypertens
diabet
chronic
lung
diseas
cardiovascular
disord
neuromuscular
diseas
independ
associ
hospit
due
laboratoryconfirm
influenza
b
influenza
viru
type
versu
b
elderli
independ
factor
associ
hospit
patient
comorbid
hypertens
diabet
chronic
lung
diseas
cardiovascular
disord
neuromuscular
diseas
greater
risk
hospit
influenza
viral
infect
physician
assess
treat
underli
comorbid
condit
well
influenza
viral
infect
appropri
manag
patient
influenza
